SE425566B - Forfarande for framstellning av erytromycinderivat och syraadditionssalter derav - Google Patents
Forfarande for framstellning av erytromycinderivat och syraadditionssalter deravInfo
- Publication number
- SE425566B SE425566B SE7604052A SE7604052A SE425566B SE 425566 B SE425566 B SE 425566B SE 7604052 A SE7604052 A SE 7604052A SE 7604052 A SE7604052 A SE 7604052A SE 425566 B SE425566 B SE 425566B
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- preparation
- additional salts
- erythromycin derivatives
- acid additional
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2515075A DE2515075C2 (de) | 1975-04-07 | 1975-04-07 | Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19762606030 DE2606030A1 (de) | 1976-02-14 | 1976-02-14 | Neue erythromycinderivate und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7604052L SE7604052L (sv) | 1976-10-08 |
SE425566B true SE425566B (sv) | 1982-10-11 |
Family
ID=25768725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7604052A SE425566B (sv) | 1975-04-07 | 1976-04-06 | Forfarande for framstellning av erytromycinderivat och syraadditionssalter derav |
Country Status (29)
Country | Link |
---|---|
US (1) | US4048306A (xx) |
JP (1) | JPS51128991A (xx) |
AT (1) | AT342770B (xx) |
AU (1) | AU498418B2 (xx) |
BG (1) | BG27380A3 (xx) |
CA (1) | CA1060005A (xx) |
CH (2) | CH621800A5 (xx) |
CS (1) | CS196304B2 (xx) |
DD (1) | DD125218A5 (xx) |
DK (1) | DK138656C (xx) |
ES (2) | ES446737A1 (xx) |
FI (1) | FI63244C (xx) |
FR (1) | FR2306703A1 (xx) |
GB (1) | GB1520963A (xx) |
GR (1) | GR60374B (xx) |
HU (1) | HU175186B (xx) |
IE (1) | IE43598B1 (xx) |
IL (1) | IL49359A (xx) |
LU (2) | LU74702A1 (xx) |
MX (1) | MX3277E (xx) |
NL (1) | NL180107C (xx) |
NO (1) | NO141411C (xx) |
NZ (1) | NZ180529A (xx) |
PL (1) | PL101880B1 (xx) |
PT (1) | PT64977B (xx) |
RO (1) | RO68441B (xx) |
SE (1) | SE425566B (xx) |
SU (1) | SU682134A3 (xx) |
YU (1) | YU87676A (xx) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3668894D1 (en) | 1985-03-12 | 1990-03-15 | Beecham Group Plc | Erythromycin-derivate. |
DE3524572A1 (de) * | 1985-07-10 | 1987-01-15 | Thomae Gmbh Dr K | Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung |
US5110800A (en) * | 1986-02-18 | 1992-05-05 | Eli Lilly And Company | Derivatives of erythromycylamine |
US4945080A (en) * | 1987-05-26 | 1990-07-31 | Eli Lilly And Company | Dirithromycin metabolite |
US5075289A (en) * | 1988-06-07 | 1991-12-24 | Abbott Laboratories | 9-r-azacyclic erythromycin antibiotics |
KR0166096B1 (ko) * | 1990-11-28 | 1999-01-15 | 우에하라 아키라 | 6-0-메틸에리쓰로마이신 a 유도체 |
US5556839A (en) * | 1991-04-29 | 1996-09-17 | Eli Lilly And Company | Form II Dirithromycin |
ZA922776B (en) * | 1991-04-29 | 1993-10-15 | Lilly Co Eli | Pharmaceutical compounds |
MY113261A (en) * | 1991-09-30 | 2002-01-31 | Lilly Co Eli | One step process for production of dirithromycin. |
DE4410637C1 (de) * | 1994-03-26 | 1995-09-21 | Boehringer Ingelheim Vetmed | Injizierbare Lösungen von Dirithromycin |
AU9645998A (en) * | 1997-10-29 | 1999-05-17 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US6436906B1 (en) | 2001-04-02 | 2002-08-20 | Enanta Pharmaceuticals, Inc. | 9-amino-14-membered macrolides derived from leucomycins |
US8313776B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
EP1648418A4 (en) | 2003-07-21 | 2011-11-16 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION |
AU2004258953B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
EP1653925A1 (en) | 2003-08-11 | 2006-05-10 | Advancis Pharmaceutical Corporation | Robust pellet |
AU2004264356B2 (en) | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
JP5686494B2 (ja) * | 2003-08-29 | 2015-03-18 | シオノギ インコーポレイテッド | 抗生物質製剤、その使用法及び作成方法 |
WO2005027877A1 (en) | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
JP2008505124A (ja) | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3660376A (en) * | 1970-09-30 | 1972-05-02 | Lilly Co Eli | N-arylidene erythromycylamines |
-
1976
- 1976-03-01 AT AT149976A patent/AT342770B/de not_active IP Right Cessation
- 1976-03-26 GR GR50399A patent/GR60374B/el unknown
- 1976-03-29 BG BG7632727A patent/BG27380A3/xx unknown
- 1976-03-29 US US05/671,421 patent/US4048306A/en not_active Expired - Lifetime
- 1976-03-30 FI FI760845A patent/FI63244C/fi not_active IP Right Cessation
- 1976-03-30 DK DK145276A patent/DK138656C/da not_active IP Right Cessation
- 1976-04-02 CH CH417476A patent/CH621800A5/de not_active IP Right Cessation
- 1976-04-05 LU LU74702A patent/LU74702A1/xx unknown
- 1976-04-05 LU LU88563C patent/LU88563I2/fr unknown
- 1976-04-05 DD DD192208A patent/DD125218A5/xx unknown
- 1976-04-06 SE SE7604052A patent/SE425566B/xx not_active IP Right Cessation
- 1976-04-06 CS CS762265A patent/CS196304B2/cs unknown
- 1976-04-06 NZ NZ180529A patent/NZ180529A/xx unknown
- 1976-04-06 GB GB13942/76A patent/GB1520963A/en not_active Expired
- 1976-04-06 MX MX000145U patent/MX3277E/es unknown
- 1976-04-06 NL NLAANVRAGE7603569,A patent/NL180107C/xx not_active IP Right Cessation
- 1976-04-06 SU SU762343016A patent/SU682134A3/ru active
- 1976-04-06 NO NO761172A patent/NO141411C/no unknown
- 1976-04-06 IL IL49359A patent/IL49359A/xx unknown
- 1976-04-06 JP JP51038681A patent/JPS51128991A/ja active Granted
- 1976-04-06 YU YU00876/76A patent/YU87676A/xx unknown
- 1976-04-06 HU HU76TO1026A patent/HU175186B/hu unknown
- 1976-04-06 AU AU12722/76A patent/AU498418B2/en not_active Expired
- 1976-04-06 CA CA249,700A patent/CA1060005A/en not_active Expired
- 1976-04-06 PL PL1976188538A patent/PL101880B1/pl unknown
- 1976-04-06 ES ES446737A patent/ES446737A1/es not_active Expired
- 1976-04-06 PT PT64977A patent/PT64977B/pt unknown
- 1976-04-06 RO RO85433A patent/RO68441B/ro unknown
- 1976-04-07 FR FR7610144A patent/FR2306703A1/fr active Granted
- 1976-04-07 IE IE732/76A patent/IE43598B1/en not_active IP Right Cessation
-
1977
- 1977-03-05 ES ES456567A patent/ES456567A1/es not_active Expired
-
1980
- 1980-04-10 CH CH277580A patent/CH624413A5/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE425566B (sv) | Forfarande for framstellning av erytromycinderivat och syraadditionssalter derav | |
SE7613565L (sv) | Forfarande for framstellning av fusidinsyraderivat | |
AR217629A1 (es) | Procedimiento de preparacion de derivados de tienotetrahidropiridina | |
SE421319B (sv) | Forfarande for framstellning av etbara polysackarider och polysackaridderivat | |
SE422937B (sv) | Forfarande for framstellning av nya propagyl-2-fenylaminoimidazolin-(2) och deras syraadditionssalter | |
SE7613839L (sv) | Forfarande for framstellning av 2(1h)-kinazolinonderivat | |
SE7707407L (sv) | Forfarande for framstellning av cefamderivat | |
SE440080B (sv) | Forfarande for framstellning av klavulansyraderivat | |
SE428688B (sv) | Forfarande for framstellning av nya antidiabetiskt aktiva isooxazolderivat | |
SE7611504L (sv) | Tiazolidinderivat och forfarande for deras framstellning | |
SE7509897L (sv) | Basiskt substituerade 3-sulfamoylbensoesyraderivat och forfarande for deras framstellning | |
SE404186B (sv) | Forfarande for framstellning av cyklopropanolderivat | |
SE422936B (sv) | Forfarande for framstellning av substituerade 2-alkylamino-4-fenylimidazoliner och deras syraadditionssalter | |
SE423814B (sv) | Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat | |
SE7614091L (sv) | Forfarande for framstellning av tiadiazolylderivat av 7-acylamido-3-cefem-4-karbonsyra | |
SE7606815L (sv) | Forfarande for framstellning av nya naftacenderivat | |
SE7600704L (sv) | Difenyleter-derivat och forfarande for framstellning derav | |
SE7607322L (sv) | Forfarande for framstellning av 16-etrar av fusidinsyraderivat | |
SE7607026L (sv) | Forfarande for framstellning av 5-alkylpikolinsyra | |
SE7808849L (sv) | Forfarande for framstellning av 9,11,15-trihydroxi-13,14-dehydroprostaglandiner och prost-5-en-13-ynsyraderivat | |
SE406586B (sv) | Nytt forfarande for framstellning av 3-fenyl-indol-2-sarbonitril och derivat derav | |
SE7604879L (sv) | 7-metoxicefalosporinderivat och forfarande for framstellning derav | |
SE427037B (sv) | Forfarande for framstellning av deoxiklavulansyra | |
SE411756B (sv) | Forfarande for framstellning av fenotiaziner, fenoxaziner och akridan-bis-pyrrolinylderivat | |
SE7602744L (sv) | Fenoxifenylsmorsyra-derivat och forfarande for framstellning derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7604052-6 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7604052-6 Format of ref document f/p: F |